MBS review process flawed: AMA

The AMA has hit out at the process the Federal Government is proposing for its MBS review, claiming it will end up fragmenting, rather than modernising, the system.

The $33 million review will see most of the 5769 items in the schedule subjected to “rapid reviews”, looking at the evidence underpinning their clinical use.

However, in its submission to the government, the AMA claims the proposed